Prof. Giorgi Pkhakadze, MD, MPH, PhD
Neurotensin Receptor 2 Activation Shows Promise in Preventing Heart Failure Progression
Activation of neurotensin receptor 2 in preclinical models significantly reduced pathological changes in heart tissue, suggesting a novel therapeutic target…
Cerebellar Cell Discovery Reshapes Understanding of Movement Disorders
Researchers have discovered that two key cerebellar cell types—long assumed to work in tandem—behave independently in many cases, challenging foundational…
Half of kidney transplant candidates never begin evaluation, US study reveals
A national cohort study reveals that 50% of Americans referred for kidney transplant evaluation never initiate the process, and only…
Would Hunters Accept a Lyme Disease Vaccine? New Research Reveals Hesitation Among High-Risk Groups
As tick populations reach decade-high levels, new research reveals vaccine hesitancy among hunters and outdoor workers despite documented occupational exposure…
AI agents AMIE and MIRA show promise in clinical decision-making, but clinical deployment remains years away
Two agentic AI models—AMIE and MIRA—have demonstrated potential in clinical decision-making across diagnosis, treatment, and hospital admission, according to Nature…
AI Agent Matches Hematology Experts in Cancer Treatment Decisions, Nature Medicine Study Shows
A case-grounded AI agent has demonstrated high concordance with hematology tumor board decisions across retrospective, external, and prospective clinical evaluations,…
WHO launches action plan to combat rising fungal disease burden and antifungal resistance
The World Health Organization has released strategic guidance to help countries address fungal disease and antifungal resistance, two major health…
MHRA Safety Roundup: June 2026 — Key Drug and Device Alerts for Clinicians
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its June 2026 safety roundup, consolidating critical alerts for…